Our group recently reported novel anti-inflammatory effects of
andrographolide (2), a bioactive molecule isolated from Andrographis paniculata, in a mouse
asthma model. However, 2 has been shown to possess cytotoxic activity.
14-Deoxy-11,12-didehydroandrographolide (1) is an analogue of 2 that can be isolated from A. paniculata. We hypothesized that 1 retains the anti-inflammatory effects for
asthma but is devoid of cytotoxicity. In contrast to 2, 1 did not elicit any cytotoxic activity in A549 and BEAS-2B human lung epithelial cells and rat basophilic
leukemia (RBL)-2H3 cells using a MTS assay. Compound 1 dose-dependently inhibited
ovalbumin (OVA)-induced increases in total and eosinophil counts,
IL-4,
IL-5, and
IL-13 levels in lavage fluid, and serum OVA-specific
IgE level in a mouse
asthma model. Compound 1 attenuated OVA-induced airway
eosinophilia, mucus production, mast cell degranulation, pro-inflammatory
biomarker expression in lung tissues, and
airway hyper-responsiveness. This substance also blocked p65 nuclear translocation and
DNA-binding activity in the OVA-challenged lung and in TNF-α-stimulated human lung epithelial cells. The present findings reveal for the first time that 1 retains the anti-inflammatory activities of 2 for
asthma probably through the inhibition of NF-κB.
14-Deoxy-11,12-didehydroandrographolide (1) may be considered as a safer analogue of 2 for the potential treatment of
asthma.